56 results on '"Okun M"'
Search Results
2. Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis
3. Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption
4. Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
5. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment
6. Does cervical dystonia in Parkinsonʼs disease respond differently to onabotulinum toxin type A compared to other causes of cervical dystonia?: 1427
7. Neuropsychological outcomes of patients with essential tremor after deep brain stimulation surgery: 1252
8. Paradoxical improvement in tremor and new onset panic pre-activation of ventral intermediate nucleus of the thalamus (VIM) deep brain stimulation: 1250
9. Effects of stimulation location on motor outcomes during current-controlled deep brain stimulation for Parkinsonʼs disease: 1180
10. Tinnitus-like sensation after deep brain stimulation surgery, a case series: 1172
11. Cooling of limbs: A cool therapy for treatment of essential tremor: 1162
12. Changes in gait performance correspond to changes in trunk tremor due to DBS in essential tremor: 1135
13. Variation in Parkinsonʼs care observed across movement disorders centers and associated variation in outcomes: 460
14. Preventable errors in hospitalized Parkinsonʼs disease patients: 442
15. Proof of concept for operation house call for underserved Parkinsonʼs disease patients: 422
16. The profile of long-term Parkinsonʼs disease survivors with 20 years disease duration and beyond: 423
17. Psychotropic medications do not increase the frequency of falls or change objective measures of walking in Parkinsonʼs: 362
18. Functional and macrostructural MRI in Parkinsonʼs disease and multiple system atrophy: 236
19. Increased motor variability in essential tremor and abnormal brain activity in the cerebellar-thalamo-cortical circuit: 228
20. Functional and macrostructural anatomy of progressive supranuclear palsy and Parkinsonʼs disease: 189
21. Analysis of tissue injury response and the microlesion effect to deep brain stimulation leads in a rat model: 94
22. The late positive potential, emotion and apathy in Parkinsonʼs disease
23. Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label Phase IIIB trial
24. Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study
25. Deep brain stimulation and the role of astrocytes
26. Unravelling the actions of deep brain stimulation: potential role for astrocytes
27. Emotion and ocular responses in Parkinsonʼs disease
28. Usefulness of Screening Tools for Predicting Driving Performance in People With Parkinsonʼs Disease
29. The national DBS brain tissue network pilot study: need for more tissue and more standardization
30. Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: results from the placebo-controlled portion of a phase II, randomized, double-blind study: O-12
31. Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
32. Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluency
33. Mood and motor effects of thalamic deep brain stimulation surgery for essential tremor
34. Interplay of Concurrent Positive and Negative Interpersonal Events in the Prediction of Daily Negative Affect and Fatigue for Rheumatoid Arthritis Patients
35. Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis
36. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience
37. Startle reflex hyporeactivity in Parkinsonʼs disease: An emotion-specific or arousal-modulated deficit?
38. Brain penetration effects of microelectrodes and DBS leads in STN or GPi
39. The Contribution of Apathy to Global Cognitive Status in Parkinsonʼs Disease: Poster 31 (PD)
40. Perceived Driving Ability of Drivers with Parkinsonʼs Disease: Poster 20 (PD)
41. Assessing Apathy with the UPDRS: Comparison to the Apathy Evaluation Scale: Poster 15 (PD)
42. LRRK2 mutations in a clinic-based cohort of Parkinsonʼs disease
43. Validation of a Computerized Neuropsychological Assessment (Mindstreams®) in Movement Disorders: Interim Analysis: Poster 27 (OMD)
44. The Florida Surgical Questionnaire for Parkinsonʼs Disease (FLASQ-PD): A Potential Triage Tool for Cognitive Dysfunction in DBS Candidates: Poster 12 (PD)
45. Abnormal Affective Startle Modulation in Psychogenic Movement Disorders: 4:15-4:30 pm
46. Is Pathological Gambling in Parkinsonʼs Disease a Compulsive or Impulsive Disorder?: 9:15-9:30 am
47. Does Perceived Cognitive Dysfunction on the PDQ-39 Correlate with Actual Cognitive Dysfunction in Parkinsonʼs Disease?: 10:30-10:45 am
48. Panic and fear induced by deep brain stimulation
49. Dystonia, tremor, and parkinsonism in a 54 year old man with 2-hydroxyglutaric aciduria
50. Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.